Interpace Biosciences, Inc. (IDXG)
1.13
+0.08
(+7.62%)
USD |
OTCM |
Jan 09, 16:00
Interpace Biosciences Total Assets (Quarterly): 12.04M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| FONAR Corp. | 218.35M |
| XWELL, Inc. | 21.74M |
| ProPhase Labs, Inc. | 65.70M |
| Veracyte, Inc. | 1.368B |
| Insight Molecular Diagnostics, Inc. | 43.94M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.33M |
| Shareholders Equity (Quarterly) | -0.298M |
| Debt to Equity Ratio | -7.584 |
| Current Ratio | 1.536 |
| Net Debt Paydown Yield | 30.76% |